Recently Tuberculosis has published the article The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development. The publication emphasizes the importance of a diverse TB vaccine pipeline to address the TB-specific challenges. Individual vaccine candidates must be advanced rationally and the global pipeline must be managed in the most nimble and resource-efficient way, especially in the current constrained funding environment.
The TB Vaccine Development Pathway has been developed as an offer to the field to provide a source of information and guidance covering vaccine development from discovery to implementation.
The Pathway is underpinned by generic and TB vaccine-specific guidelines, regulatory frameworks and best practice, and was compiled by a multi-disciplinary team of scientific and technical experts with the input of the TB vaccine community. The Pathway is a unique tool to guide and accelerate the development of TB vaccine candidates and may be useful for other vaccine development fields.